Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, it uses innovative science and digital technologies to create transformative treatments in areas of great medical need.

In Romania, Novartis Group, with its three divisions – Novartis Pharma, Novartis Oncology and Sandoz – is a leading medicines company, with over 650 associates committed to support Romanians healthcare. Based on the number of clinical trials initiated in the last decade in Romania, Novartis Group in Romania is the number 1 company that invests in research and development.

The production site in Targu Mures produces medicines for Romania and for more than 60 other countries in Europe, North America and beyond. The company offers a complex portfolio of innovative, generic and biosimilar therapies covering areas like oncology, cardiovascular, immunology, dermatology, neurology, ophthalmology, respiratory, and others.

Novartis Group is present in Romania through three legal entities Novartis Pharma Service Romania SRL (that includes Pharma and Oncology divisions), Sandoz Pharma Services SRL and Sandoz SRL.